TTN and hydrops fetalis: Finally, PTMs of titin that alter titin‐based myocardial passive stiffness represent a promising potential target for therapeutic intervention in HF patients with overly stiff hearts (such as in HFpEF), despite recent setbacks in some preclinical studies regarding to the role of cGMP‐PKG activation for myocardial stiffness in vivo.